After a drug target is identified and validated, research now focuses on lead discovery, also known as lead identification and screening, in which multiple drug candidates are developed. Leads must be shown to reach the target and modulate its activity in vivo while acting within acceptable safety margins. At this stage, high-throughput screening is typically used to identify promising candidates for a lead (hit-to-lead). Show more
Potential leads are evaluated for a range of properties that can include selectivity, binding mechanism(s) and kinetic analysis, dose-response curves, tractability to modifications, potency, in vitro toxicity, and orthogonal testing. Based on the results of this initial testing regimen, new lead-related candidates are evaluated, for example, antibodies optimized by protein engineering for increased efficacy and specificity or reduced immunogenicity. This stage is known as lead optimization. Show less
Featured Article Advantages of Multidimensional (Multi-D) Chromatography Using the NGC™ Chromatography System over Traditional Sequential Chromatography
Measure gene expression and copy number variation (CNV) in response to lead molecule screening with high sensitivity and absolute quantitation using Droplet Digital™ PCR. Utilize our automated real-time PCR systems and liquid handling systems for higher-throughput analysis needs. Combine these with our validated PCR primers for guaranteed lead discovery assay performance.
Droplet Digital PCR Systems Real-Time PCR Automation
Choose from a broad selection of chromatography columns and resins and modular FPLC systems for rapid purification of your lead molecules, antibodies or other proteins of interest. Evaluate and quantitate proteins using a range of complementary technologies.
Multiplex Immunoassays Western Blotting Reagents and Equipment GS-900™ Calibrated Densitometer and Regulatory Tools NGC™ Medium-Pressure Chromatography Systems Chromatography Columns and Resins
For evaluation of the effects of lead molecules on cells, as in high-content screening (HCS) methods, Bio-Rad offers equipment for cell counting, cell sorting, and flow cytometric analysis.
Cell ImagingCell Counting Cell Sorting and Flow Cytometry Antibodies for Flow Cytometry
Choose from an extensive range of antibodies for use in your screening assays or utilize our custom antibody services.
Antibodies by Application Antibodies by Target Species HuCAL® Custom Antibody Services Human Immunoglobulin Isotyping Assays Immunology Antibodies Isotype Controls
Biomarker DiscoveryThe use of biomarkers across drug discovery and development and into the clinic is key to enabling close monitoring of a drug candidate’s effects. Biomarkers can range from specific molecules such as a protein, a gene sequence, or expressed RNA to physiological parameters such as blood pressure. Biomarkers may be detected in a specific location or tissue or in plasma and other bodily fluids.
Biochemical and Cellular AssaysBiochemical and cellular pharmacology teams develop and validate assays to support research across drug discovery and development. These assays range from discovery approaches with high sample throughput to high-content analysis to gain an understanding of biological response both in vitro and in vivo.
Call us at 1-800-4-BIORAD (1-800-424-6723)
Please reenter your email address in the correct format.
Please enter your email address.
Your subscription information already exists, we will send you an email with specific instructions to manage your existing subscription profile.
To receive the latest news, promotions, and more, sign up for Bio-Rad updates by entering your email address below. You can elect to receive only the types of Bio-Rad communications that are of interest to you..
Copyright © 2016 Bio-Rad Laboratories, Inc. All rights reserved.